Clinical Trials Directory

Trials / Completed

CompletedNCT01740817

A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling

A Randomized, Crossover Study to Evaluate the Effect of Lipid Infusion on TLR4 Signaling and Insulin Resistance in Human Muscle

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
The University of Texas Health Science Center at San Antonio · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether a lipid infusion can up-regulate toll-like receptor 4 (TLR4) signaling in human subjects

Detailed description

The investigators plan to examine the effect of a lipid infusion on TLR4 expression and insulin sensitivity. A group of 30 subjects aged 18-60 years old, lean (BMI \< 26 kg/m2) normal glucose tolerant subjects without a family history of type 2 diabetes will receive a lipid or saline infusion. The subjects will be randomly assigned to first receive either a 48 hour long lipid or saline infusion. Approximately 4-6 weeks later subjects will return to undergo another study (if, in the first study they received lipid, on the second study they will receive saline, and vice versa). A near-equal number of women and men will be included in each group.

Conditions

Interventions

TypeNameDescription
DRUGIntralipid 20%30 ml/h for 48 h
DRUGSaline30 ml/h for 48 h

Timeline

Start date
2008-01-01
Primary completion
2013-12-01
Completion
2015-09-01
First posted
2012-12-04
Last updated
2016-01-25
Results posted
2016-01-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01740817. Inclusion in this directory is not an endorsement.